about
Interferons as inducers of apoptosis in malignant cellsIFN-λ: A New Inducer of Local Immunity against Cancer and InfectionsRespiratory syncytial virus can infect basal cells and alter human airway epithelial differentiationInterferons and their receptors in birds: a comparison of gene structure, phylogenetic analysis, and cross modulationOsteosarcoma Overview.Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured.Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysisNK cells require IL-28R for optimal in vivo activityInterleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage functionStructural analysis of tumor-related single amino acid mutations in human MxA proteinThe impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis CSprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesTemperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype.IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.Investigations of interferon-lambda for the treatment of cancer.IFN-λ cancer immunotherapy: new kid on the block.Effect of Interleukin-29 on Interferon-α Secretion by Peripheral Blood Mononuclear Cells.Adenovirus expressing IFN-λ (Ad/hIFN-λ) produced anti-tumor effects through inducing apoptosis in human tongue squamous cell carcinoma cell.A discrete population of IFN λ-expressing BDCA3hi dendritic cells is present in human thymus.Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women.Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells
P2860
Q27010207-F2D1B874-0103-4288-9AF7-8B86F42F02BFQ28072995-7C58D5D9-F784-426B-94E7-A7A7571627E5Q28540852-3DDF3C5D-8E9B-4539-8DF4-55888E94E547Q28649915-AAC15BBF-063C-47DE-A913-48E3B51D691AQ33725511-6CF919C1-37F8-44D2-A3A4-D5092353BCA8Q34278413-998D09B6-E495-4D6C-A87E-F894C22851B3Q34653087-CBECC1FF-91EA-4F82-97FF-D693DEA7E071Q35590214-4C065596-82C9-49E2-9B31-A04BD272CE9FQ35884586-DE9FE369-2A8E-4CDC-B3EA-21A8A1DD744DQ36121243-5841DFE5-F3EF-4595-9CEC-CE3274E9E57AQ36208380-EEE11810-673B-4300-BDB5-E9B2FD76D92EQ36452049-018C5C4C-D18F-4773-AC36-DC34F5850578Q37377964-EF113D09-51E5-4EA3-AEFA-529278DECF56Q37681541-E19F53F5-F6D8-42AB-8349-01F716A79592Q38101865-489C18C4-D124-4C50-BF1A-D9ACE3A53A47Q38347596-6C35AF16-55EF-4BF0-A7EC-E4CDD596B45BQ38887297-563E78C7-20A3-4DF5-ADEB-CBC974A2620BQ39038507-56ACD2CE-3A0F-4AAF-9575-046592838C90Q40917578-5717363D-6D6E-4AE6-B3B3-CB9B9443D8C0Q41441925-7E7D2B02-88FC-40C7-B1B4-1D136C83EE01Q41495145-3D8FA910-189C-4A63-951E-972ED1D4968AQ42238119-ACFCBB0B-6FE5-4E86-B832-BC8BBB79F0CFQ52648279-7AEA472D-0716-4375-ACE9-F83517F5DAFEQ55003290-320F3603-89C7-4177-86EB-77722DBE9C9AQ57818348-CF70F7D5-CCF6-4564-84D2-1027433A3598
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interferon lambda: a new sword in cancer immunotherapy
@ast
Interferon lambda: a new sword in cancer immunotherapy
@en
Interferon lambda: a new sword in cancer immunotherapy
@en-gb
Interferon lambda: a new sword in cancer immunotherapy
@nl
type
label
Interferon lambda: a new sword in cancer immunotherapy
@ast
Interferon lambda: a new sword in cancer immunotherapy
@en
Interferon lambda: a new sword in cancer immunotherapy
@en-gb
Interferon lambda: a new sword in cancer immunotherapy
@nl
altLabel
Interferon Lambda: A New Sword in Cancer Immunotherapy
@en
prefLabel
Interferon lambda: a new sword in cancer immunotherapy
@ast
Interferon lambda: a new sword in cancer immunotherapy
@en
Interferon lambda: a new sword in cancer immunotherapy
@en-gb
Interferon lambda: a new sword in cancer immunotherapy
@nl
P2093
P2860
P921
P356
P1476
Interferon lambda: a new sword in cancer immunotherapy
@en
P2093
Ahmed Lasfar
Karine A Cohen-Solal
Murugabaskar Balan
Walid Abushahba
P2860
P304
P356
10.1155/2011/349575
P407
P5008
P577
2011-12-06T00:00:00Z